These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17659484)

  • 21. Recent advances in the discovery of 11beta-HSD1 inhibitors.
    Boyle CD
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):495-511. PubMed ID: 18600567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
    Proença C; Oliveira A; Freitas M; Ribeiro D; Sousa JLC; Ramos MJ; Silva AMS; Fernandes PA; Fernandes E
    J Nat Prod; 2020 May; 83(5):1541-1552. PubMed ID: 32364726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of
    Zhou J; Bie J; Wang X; Liu Q; Li R; Chen H; Hu J; Cao H; Ji W; Li Y; Liu S; Shen Z; Xu B
    J Med Chem; 2020 Sep; 63(18):10307-10329. PubMed ID: 32820629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand-based designing, in silico screening, and biological evaluation of new potent fructose-1,6-bisphosphatase (FBPase) inhibitors.
    Tayyem RF; Zalloum HM; Elmaghrabi MR; Yousef AM; Mubarak MS
    Eur J Med Chem; 2012 Oct; 56():70-95. PubMed ID: 22960695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fructose-1,6-bisphosphatase in stage VI frog oocytes: evidence for an active enzyme in vivo.
    Preller A; Guixé V; Kessi E; Ureta T
    Arch Biochem Biophys; 1995 Jan; 316(1):555-60. PubMed ID: 7840666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mononuclear and polymorphonuclear leukocytes show increased fructose-1,6-bisphosphatase activity in patients with type 1 diabetes mellitus.
    Sybirna N; Dziewulska-Szwajkowska D; Barska M; Dzugaj A
    Cell Biol Int; 2006 Jul; 30(7):624-30. PubMed ID: 16725352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of novel indole derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.
    Bie J; Liu S; Li Z; Mu Y; Xu B; Shen Z
    Eur J Med Chem; 2015 Jan; 90():394-405. PubMed ID: 25461330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calculation of relative binding affinities of fructose 1,6-bisphosphatase mutants with adenosine monophosphate using free energy perturbation method.
    Mutyala R; Reddy RN; Sumakanth M; Reddanna P; Reddy MR
    J Comput Chem; 2007 Apr; 28(5):932-7. PubMed ID: 17253638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between muscle aldolase and muscle fructose 1,6-bisphosphatase results in the substrate channeling.
    Rakus D; Pasek M; Krotkiewski H; Dzugaj A
    Biochemistry; 2004 Nov; 43(47):14948-57. PubMed ID: 15554702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of fructose-2,6-bisphosphatase inhibitors: a novel virtual screening approach.
    Shaikh MS; Mittal A; Bharatam PV
    J Mol Graph Model; 2008 Feb; 26(6):900-6. PubMed ID: 17644015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric FBPase inhibitors gain 10(5) times in potency when simultaneously binding two neighboring AMP sites.
    Hebeisen P; Kuhn B; Kohler P; Gubler M; Huber W; Kitas E; Schott B; Benz J; Joseph C; Ruf A
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4708-12. PubMed ID: 18650089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological evaluation and SAR analysis of novel covalent inhibitors against fructose-1,6-bisphosphatase.
    Han X; Huang Y; Wei L; Chen H; Guo Y; Tang Z; Hu W; Xia Q; Wang Q; Yan J; Ren Y
    Bioorg Med Chem; 2020 Sep; 28(18):115624. PubMed ID: 32828433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzoxazole benzenesulfonamides are novel allosteric inhibitors of fructose-1,6-bisphosphatase with a distinct binding mode.
    von Geldern TW; Lai C; Gum RJ; Daly M; Sun C; Fry EH; Abad-Zapatero C
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1811-5. PubMed ID: 16442285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fructose 1,6-
    Timson DJ
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30804231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and structure-activity relationship of non-phosphorus-based fructose-1,6-bisphosphatase inhibitors: 2,5-Diphenyl-1,3,4-oxadiazoles.
    Liao BR; He HB; Yang LL; Gao LX; Chang L; Tang J; Li JY; Li J; Yang F
    Eur J Med Chem; 2014 Aug; 83():15-25. PubMed ID: 24946215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fructose-1,6-bisphosphatase Inhibitors: A Review of Recent (2000- 2017) Advances and Structure-Activity Relationship Studies.
    Singh S; Harmalkar DS; Choi Y; Lee K
    Curr Med Chem; 2019; 26(29):5542-5563. PubMed ID: 30182843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel heteroaromatic organofluorine inhibitors of fructose-1,6-bisphosphatase.
    Rudnitskaya A; Huynh K; Török B; Stieglitz K
    J Med Chem; 2009 Feb; 52(3):878-82. PubMed ID: 19143528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managlinat dialanetil, a fructose-1,6-bisphosphatase inhibitor for the treatment of type 2 diabetes.
    Wang Y; Tomlinson B
    Curr Opin Investig Drugs; 2007 Oct; 8(10):849-58. PubMed ID: 17907062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization of chicken muscle FBPase in cardiomyocyte nuclei.
    Zmojdzian M; Dziewulska-Szwajkowska D; Dzugaj A
    Comp Biochem Physiol B Biochem Mol Biol; 2005 Jan; 140(1):37-43. PubMed ID: 15621507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newly approved and promising antidiabetic agents.
    Combettes M; Kargar C
    Therapie; 2007; 62(4):293-310. PubMed ID: 17983555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.